Therapeutic Uses of Compounds Having Combined SERT, 5-HT3 and 5-HT1A Activity
- 专利权人:
- H. Lundbeck A/S;Takeda Pharmaceuticals U.S.A., Inc.
- 发明人:
- Nicholas Moore,Marianne Dragheim
- 申请号：
- US15043167
- 公开号：
- US20160228430A1
- 申请日:
- 2016.02.12
- 申请国别(地区):
- US
- 年份:
- 2016
- 代理人:
- 摘要：
- New pharmaceutical uses of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine and pharmaceutically acceptable salts thereof are provided.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1A activity
- Therapeutic uses of compounds with combined sert, 5-HT3 and 5-HT1A activity
- Therapeutic Uses of Compounds Having Combined SERT, 5-HT3 and 5-HT1A Activity
- Therapeutic uses of compounds having combined sert, 5-HT3 and 5-HT1A activity
- THERAPEUTIC USES OF COMPOUNDS HAVING COMBINED SERT, 5-HT3 AND 5-HT1A ACTIVITY
